Indonesia’s Bio Farma Gains Boost From Germany’s Artes Biotechnology To Expand Vaccines Output
This article was originally published in PharmAsia News
Bio Farma says new technology will help expand vaccines production and work on a hepatitis B vaccine as the country moves to launch a phased universal health care insurance program next year.
You may also be interested in...
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.
Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.